Trial · NCT03315689
Adverse events33
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 33
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Application site erosion | General disorders | Vehicle Topical Solution | 0 | 4 | 0 |
| other | Application site erosion | General disorders | ATI-50002 0.46% Topical Solution | 0 | 7 | 0 |
| other | Application site erosion | General disorders | ATI-50002 0.46% Topical Solution OLE | 1 | 10 | 1 |
| other | Peripheral swelling | General disorders | Vehicle Topical Solution | 0 | 4 | 0 |
| other | Peripheral swelling | General disorders | ATI-50002 0.46% Topical Solution | 0 | 7 | 0 |
| other | Peripheral swelling | General disorders | ATI-50002 0.46% Topical Solution OLE | 1 | 10 | |
| other | Ear infection | Infections and infestations | Vehicle Topical Solution | 0 | 4 | 0 |
| other | Ear infection | Infections and infestations | ATI-50002 0.46% Topical Solution | 0 | 7 | 0 |
| other | Ear infection | Infections and infestations | ATI-50002 0.46% Topical Solution OLE | 1 | 10 | 1 |
| other | Oral herpes | Infections and infestations | Vehicle Topical Solution | 0 | 4 | 0 |
| other | Oral herpes | Infections and infestations | ATI-50002 0.46% Topical Solution | 0 | 7 | 0 |
| other | Oral herpes | Infections and infestations | ATI-50002 0.46% Topical Solution OLE | 1 | 10 | 1 |
| other | Dehydration | Metabolism and nutrition disorders | Vehicle Topical Solution | 0 | 4 | 0 |
| other | Dehydration | Metabolism and nutrition disorders | ATI-50002 0.46% Topical Solution | 0 | 7 | 0 |
| other | Dehydration | Metabolism and nutrition disorders | ATI-50002 0.46% Topical Solution OLE | 1 | 10 | 1 |
| other | Glucose tolerance impaired | Metabolism and nutrition disorders | Vehicle Topical Solution | 0 | 4 | 0 |
| other | Glucose tolerance impaired | Metabolism and nutrition disorders | ATI-50002 0.46% Topical Solution | 0 | 7 | 0 |
| other | Glucose tolerance impaired | Metabolism and nutrition disorders | ATI-50002 0.46% Topical Solution OLE | 1 | 10 | 1 |
| other | Vitamin D deficiency | Metabolism and nutrition disorders | Vehicle Topical Solution | 0 | 4 | 0 |
| other | Vitamin D deficiency | Metabolism and nutrition disorders | ATI-50002 0.46% Topical Solution | 0 | 7 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03315689/events